Transcription

MEDICAID PHARMACY PRIOR AUTHORIZATION ADVISORY COMMITTEERecommendations SummaryMay 10, 2017In Attendance:Committee MemberYes or No1Rosanne BarberYes2Robert Rohloff, M.D.Yes - left @ 12:00 p.m.4Catherine Decker, Pharm.D.Yes - arrived @ 9:40 a.m.6John Fangman, M.D.Yes7Kevin Izard, M.D.Yes - arrived @ 10:00 a.m.8Steve Maike, RPhYes9William E. Raduege, M.D.Yes10Pat TowersYes11Alicia Walker, Pharm.D.Yes12Michael Witkovsky, M.D.Yes - arrived @ 9:25 a.m.

MAY 2017 THERAPEUTIC DRUG CLASSACNE AGENTS, TOPICALANALGESICS, MISCELLANEOUSANALGESICS, NARCOTICS LONGANALGESICS, NARCOTICS SHORTANDROGENIC AGENTSANGIOTENSIN MODULATOR COMBINATIONSANGIOTENSIN MODULATORSANTIBIOTICS, GIANTIBIOTICS, INHALEDANTIBIOTICS, TOPICALANTIBIOTICS, VAGINALANTICOAGULANTSANTIEMETIC/ANTIVERTIGO AGENTSANTIFUNGALS, ORALANTIFUNGALS, TOPICALANTIMIGRAINE AGENTSANTIPARTASITICS, TOPICALANTIVIRALS, ORALANTIVIRALS, TOPICALBETA BLOCKERSBLADDER RELAXANT PREPARATIONSBONE RESORTPION SUPPRESSION AND RELATED AGENTSBPH TREATMENTSCALCIUM CHANNEL BLOCKERSCEPHALOSPORINS AND RELATED AGENTSFLUOROQUINOLONES, ORALGI MOTILITY, CHRONICGROWTH HORMONEH. PYLORI TREATMENTHEPATITIS B AGENTSHEPATITIS C AGENTSHYPOGLYCEMICS, ALPHA-GLUCOSIDASE INHIBITORSHYPOGLYCEMICS, INCRETIN MIMETICS/ENHANCERSHYPOGLYCEMICS, INSULIN AND RELATED AGENTSHYPOGLYCEMICS, MEGLITINIDESHYPOGLYCEMICS, OTHERHYPOGLYCEMICS, SULFONYLUREASHYPOGLYCEMICS, TZDLIPOTROPICS, OTHERLIPOTROPICS, STATINSMACROLIDES/KETOLIDESMULTIPLE SCLEROSIS AGENTSOPIATE DEPENDENCE TREATMENTSPAH AGENTS, ORAL AND INHALEDPANCREATIC ENZYMESPENICILLINSPHOSPHATE BINDERSPLATELET AGGREGATION INHIBITORSPROTON PUMP INHIBITORSSKELETAL MUSCLE RELAXANTSTETRACYCLINESULCERATIVE COLITIS AGENTS

Recommendations Summary:The following drug classes presented for review had no recommended changes since theNovember 11, 2016 Wisconsin Medicaid Pharmacy PA Advisory Committee (PAC). The PAChad no additional discussion regarding these drug classes.Drug Classes included in the committee block vote: ANALGESICS, MISCELLANEOUSANDROGENIC AGENTSANTIBIOTICS, INHALEDANTIBIOTICS, TOPICALANTICOAGULANTSANTIFUNGALS, ORALANTIFUNGALS, TOPICALANTIVIRALS, TOPICALBETA BLOCKERSBONE RESORPTION SUPPRESSION AND RELATED AGENTSCALCIUM CHANNEL BLOCKERSCEPHALOSPORINS AND RELATED AGENTSFLUOROQUINOLONESH. PYLORI TREATMENTHEPATITIS C AGENTSHYPOGLYCEMICS, MEGLITINIDESHYPOGLYCEMICS, METFORMINSHYPOGLYCEMICS, SULFONYLUREASHYPOGLYCEMICS, TZDPANCREATIC ENZYMESPENICILLINSPHOSPHATE BINDERSPROTON PUMP INHIBITORSSKELETAL MUSCLE RELAXANTS Discussion: John Fangman thanked the Department for its efforts both in general andspecifically with the Hepatitis C Agents class. He commended the Department for beingresponsive to the needs of prescribers and members, ensuring members have access toclinically sound treatment with a fiscally responsible approach. Kevin Izard made a motion to accept staff recommendations as presented.o Second - Roseanne Barbero All members were in favor of the motiono Motion passes

ACNE AGENTS, TOPICALBrand NameCurrentMarketShareVELTIN (TOPICAL)0.0%BENZACLIN W/PUMP (TOPICAL)0.0%BENZOYL PEROXIDE LOTION OTC (TOPICAL)0.1%AZELEX (TOPICAL)1.5%RETIN-A GEL (TOPICAL)3.2%BENZOYL PEROXIDE 5% WASH OTC (TOPICAL)4.0%TAZORAC GEL (TOPICAL)0.2%ONEXTON W/PUMP (TOPICAL)0.0%EPIDUO (TOPICAL)8.3%TAZORAC CREAM (TOPICAL)0.3%ACANYA W/PUMP (TOPICAL)0.0%DIFFERIN LOTION (TOPICAL)0.2%RETIN-A CREAM (TOPICAL)13.6%DIFFERIN CREAM (TOPICAL)4.0%BENZOYL PEROXIDE GEL OTC (TOPICAL)9.9%DIFFERIN GEL (TOPICAL)6.5%DIFFERIN GEL PUMP (TOPICAL)2.1%BENZOYL PEROXIDE 10% WASH OTC (TOPICAL)3.1%ZIANA (TOPICAL)0.0%RETIN-A MICRO 0.08% PUMP (TOPICAL)0.0%ERYTHROMYCIN-BENZOYL PEROXIDE (TOPICAL)0.1%ERYTHROMYCIN GEL (AG) (TOPICAL)0.0%BENZACLIN (TOPICAL)0.0%AVITA GEL (TOPICAL)0.0%BENZOYL PEROXIDE CLEANSER (TOPICAL)0.0%ERYTHROMYCIN SOLUTION (TOPICAL)1.2%CLINDAMYCIN PHOSPHATE SOLUTION (TOPICAL)9.2%EPIDUO FORTE GEL W/PUMP (TOPICAL)0.1%AVITA CREAM (TOPICAL)0.0%TRETINOIN MICROSPHERES GEL 0.04%, 0.1% (AG) (TOPICAL)0.0%ACZONE GEL (TOPICAL)0.3%SULFACETAMIDE / SULFUR SUSPENSION (TOPICAL)0.0%SULFACETAMIDE / SULFUR CLEANSER (TOPICAL)1.0%CLINDAMYCIN PHOSPHATE GEL (TOPICAL)28.7%FABIOR (TOPICAL)0.0%SULFACETAMIDE SUSPENSION (TOPICAL)0.1%TRETINOIN MICROSPHERES GEL 0.04%, 0.1% PUMP (AG) (TOPICAL)0.0%SULFACETAMIDE SODIUM/SULFUR (TOPICAL)0.0%TRETINOIN GEL (AVITA, RETIN-A) (TOPICAL)0.1%TRETINOIN CREAM (TOPICAL)0.7%CLINDAMYCIN PHOSPHATE LOTION (TOPICAL)0.6%SULFACETAMIDE CLEANSER (TOPICAL)0.0%CLINDAMYCIN / BENZOYL PEROXIDE (DUAC) (TOPICAL)0.1%ERYTHROMYCIN GEL (TOPICAL)0.1%ADAPALENE GEL (AG) (TOPICAL)0.0%ADAPALENE GEL (TOPICAL)0.1%BENZOYL PEROXIDE FOAM (TOPICAL)0.0%ADAPALENE CREAM (TOPICAL)0.0%BENZEPRO CLEANSER (TOPICAL)0.0%KLARON (TOPICAL)0.0%BENZOYL PEROXIDE MICROSPHERES CLEANSER (TOPICAL)0.0%ADAPALENE GEL PUMP (AG) (TOPICAL)0.0%ADAPALENE GEL PUMP (TOPICAL)0.0%TRETINOIN GEL (ATRALIN) (TOPICAL)0.0%SULFACETAMIDE SODIUM/SULFUR CREAM (TOPICAL)0.0%SULFACETAMIDE / SULFUR / UREA CLEANSER (TOPICAL)0.0%CLINDAMYCIN / BENZOYL PEROXIDE (BENZACLIN) (TOPICAL)0.1%SULFACETAMIDE / SULFUR LOTION (TOPICAL)0.0%ACZONE GEL W/PUMP (TOPICAL)0.1%CLINDAMYCIN / BENZOYL PEROXIDE (BENZACLIN) W/PUMP (TOPICAL) 0.0%BENZAMYCIN (TOPICAL)0.0%BENZOYL PEROXIDE GEL (TOPICAL)0.0%TRETINOIN MICROSPHERES GEL 0.04%, 0.1% (TOPICAL)0.1%ATRALIN (TOPICAL)0.0%RETIN-A MICRO 0.04%, 0.1% (TOPICAL)0.1%SULFACETAMIDE SODIUM/SULFUR LOTION (TOPICAL)0.0%AVAR FOAM (TOPICAL)0.0%OVACE PLUS FOAM (TOPICAL)0.0%CLINDAMYCIN PHOSPHATE FOAM (TOPICAL)0.0%PLEXION CLEANSER (TOPICAL)0.0%RETIN-A MICRO 0.04%, 0.1% PUMP (TOPICAL)0.0%OVACE PLUS WASH (TOPICAL)0.0%BP 10-1 (TOPICAL)0.0%TRETINOIN MICROSPHERES GEL 0.04%, 0.1% PUMP (TOPICAL)0.0%AVAR CLEANSER (TOPICAL)0.0%CLINDAMYCIN / TRETINOIN (TOPICAL)0.0%CLINDAGEL DIFICATIONS

Discussion: None William Raduege made a motion to accept staff recommendations as presented.o Second - Alicia Walkero All members were in favor of the motiono Motion passesANALGESICS, NARCOTICS LONGBrand NameCurrentMarketShareMETHADONE SOL TABLET (ORAL)0.0%METHADONE TABLET (ORAL)9.6%NUCYNTA ER (ORAL)1.0%TRAMADOL ER (ULTRAM ER) (ORAL)0.5%METHADONE SOLUTION (ORAL)0.2%MORPHINE ER TABLET (ORAL)37.5%TRAMADOL ER (RYZOLT) (ORAL)0.0%HYSINGLA ER (ORAL)2.5%EMBEDA (ORAL)0.2%FENTANYL (TRANSDERM)19.5%BUTRANS (TRANSDERM)7.1%KADIAN (ORAL)1.3%METHADONE CONC (ORAL)0.0%OPANA ER (ORAL)0.9%TRAMADOL ER (CONZIP) (AG) (ORAL)0.0%OXYCONTIN (ORAL)17.2%MORPHINE ER CAPSULE (AVINZA) (ORAL)0.0%ZOHYDRO ER (ORAL)0.1%BELBUCA (BUCCAL)0.1%MORPHINE ER CAPSULE (KADIAN) (ORAL)0.0%XTAMPZA ER (ORAL)0.0%CONZIP (ORAL)0.0%OXYCODONE ER (AG) (ORAL)1.6%FENTANYL (37.5, 62.5, 87.5 MG) (TRANSDERM) 0.0%OXYMORPHONE ER (ORAL)0.4%HYDROMORPHONE ER (AG) (ORAL)0.0%HYDROMORPHONE ER (ORAL)0.2%EXALGO CATIONS Discussion: Rachel Currans-Henry stated that methadone dosage forms for pain weredesignated as non-preferred in 2016, and since that change, utilization of methadone hasdecreased by approximately thirty percent. Michael Witkovsky made a motion to accept staff recommendations as presented.o Second - Pat Towerso All members were in favor of the motiono Motion passes

ANALGESICS, NARCOTICS SHORTBrand NameDILAUDID LIQUID (ORAL)MEPERIDINE SOLUTION (ORAL)TRAMADOL (ORAL)APAP / CODEINE ELIXIR (ORAL)APAP / CODEINE TABLET (ORAL)HYDROCODONE / APAP TABLET (ORAL)MORPHINE IR TABLET (ORAL)MORPHINE SOLUTION (ORAL)HYDROMORPHONE TABLET (ORAL)MEPERIDINE TABLET (ORAL)MORPHINE CONC SOLUTION (ORAL)OXYCODONE TABLET (ORAL)HYDROCODONE / IBUPROFEN (ORAL)NUCYNTA (ORAL)OXYCODONE / APAP TABLET (ORAL)CODEINE (ORAL)TRAMADOL / APAP (ORAL)OXYCODONE SOLUTION (ORAL)OXYCODONE / ASA (ORAL)IBUDONE (ORAL)BUTORPHANOL TARTRATE (NASAL)LORTAB (ORAL)DIHYDROCODEINE / ASA / CAFFEINE (AG) (ORAL)HYCET (ORAL)HYDROCODONE / APAP SOLUTION (ORAL)HYDROMORPHONE SUPPOSITORIES (RECTAL)OXYCODONE / APAP SOLUTION (ORAL)HYDROMORPHONE LIQUID (ORAL)BUTALBITAL / CAFFEINE / APAP W/CODEINE (ORAL)OXYCODONE / IBUPROFEN (ORAL)ABSTRAL (SUBLINGUAL)DIHYDROCODEINE / APAP / CAFFEINE (ORAL)BUTALBITAL COMPOUND W/CODEINE (ORAL)REPREXAIN (ORAL)CARISOPRODOL COMPOUND-CODEINE (ORAL)XARTEMIS XR (ORAL)OXYCODONE CAPSULE (ORAL)ZAMICET (ORAL)MORPHINE SUPPOSITORIES (RECTAL)NORCO (ORAL)OXYMORPHONE (ORAL)PENTAZOCINE / NALOXONE (ORAL)FIORICET / CODEINE (ORAL)OXYCODONE CONC (ORAL)FENTORA (BUCCAL)CAPITAL W-CODEINE (ORAL)PRIMLEV (ORAL)FENTANYL (BUCCAL)LEVORPHANOL (ORAL)LAZANDA (NASAL)SUBSYS MODIFICATIONS Discussion: Rachel Currans-Henry stated that the recommendation to non-prefer codeineis based on the population being served and safety concerns when used to treat children.The Wisconsin Medicaid Drug Utilization Review Committee is reviewing opiate use bychildren less than 18 years old, focusing specifically on codeine and Tramadol. William Raduege made a motion to accept staff recommendations as presented.o Second - Catherine Deckero All members were in favor of the motiono Motion passes

ANGIOTENSIN MODULATOR COMBINATIONSBrand NameCurrentMarketShareTARKA (ORAL)0.3%AMLODIPINE / VALSARTAN (AG) (ORAL)9.6%TRIBENZOR (ORAL)23.4%EXFORGE HCT (ORAL)9.6%AMLODIPINE / BENAZEPRIL (ORAL)10.4%AZOR (ORAL)32.7%TWYNSTA (ORAL)0.0%AMLODIPINE / VALSARTAN (ORAL)2.2%AMLODIPINE / OLMESARTAN (AG) (ORAL)1.6%AMLODIPINE / VALSARTAN / HCTZ (AG) (ORAL)0.0%AMLODIPINE / OLMESARTAN / HCTZ (AG) (ORAL)0.8%PRESTALIA (ORAL)0.0%BYVALSON (ORAL)0.0%TRANDOLAPRIL / VERAPAMIL (AG) (ORAL)0.0%AMLODIPINE / VALSARTAN / HCTZ (ORAL)0.0%TELMISARTAN / AMLODIPINE (ORAL)0.1%AMLODIPINE / OLMESARTAN / HCTZ (ORAL)6.5%AMLODIPINE / OLMESARTAN EMODIFICATIONS Discussion: None John Fangman made a motion to accept staff recommendations as presented.o Second - Steve Maikeo All members were in favor of the motiono Motion passesSECRETARYMODIFICATIONS

ANGIOTENSIN MODULATORSBrand NameLISINOPRIL HCTZ (ORAL)ENALAPRIL HCTZ (ORAL)QUINAPRIL HCTZ (ORAL)MOEXIPRIL HCTZ (ORAL)BENAZEPRIL HCTZ (ORAL)FOSINOPRIL HCTZ (ORAL)CAPTOPRIL HCTZ (ORAL)LISINOPRIL (ORAL)BENAZEPRIL (ORAL)RAMIPRIL (ORAL)FOSINOPRIL (ORAL)QUINAPRIL (ORAL)PERINDOPRIL (ORAL)ENALAPRIL (ORAL)TRANDOLAPRIL (ORAL)QBRELIS SOLUTION (ORAL)MOEXIPRIL (ORAL)CAPTOPRIL (ORAL)EPANED KIT (ORAL)EPANED SOLUTION (ORAL)BENICAR (ORAL)MICARDIS (ORAL)EDARBI (ORAL)LOSARTAN (ORAL)IRBESARTAN (ORAL)VALSARTAN (AG) (ORAL)VALSARTAN (ORAL)CANDESARTAN (AG) (ORAL)TELMISARTAN (AG) (ORAL)TELMISARTAN (ORAL)CANDESARTAN (ORAL)EPROSARTAN (ORAL)OLMESARTAN (AG) (ORAL)OLMESARTAN HCTZ (AG) (ORAL)OLMESARTAN HCTZ (ORAL)OLMESARTAN (ORAL)ENTRESTO (ORAL)MICARDIS HCT (ORAL)EDARBYCLOR (ORAL)LOSARTAN HCTZ (ORAL)IRBESARTAN HCTZ (ORAL)BENICAR HCT (ORAL)VALSARTAN HCTZ (ORAL)TELMISARTAN HCTZ (AG) (ORAL)CANDESARTAN HCTZ (ORAL)TELMISARTAN HCTZ (ORAL)TEKTURNA HCT (ORAL)TEKTURNA IONSSTATEMODIFICATIONSSECRETARYMODIFICATIONS Discussion: None Michael Witkovsky made a motion to accept staff recommendations as presented.o Second - Pat Towerso All members were in favor of the motiono Motion passes

ANTIBIOTICS, GIBrand NameMETRONIDAZOLE TABLET (ORAL)NEOMYCIN (ORAL)TINIDAZOLE (ORAL)METRONIDAZOLE CAPSULE (ORAL)TINDAMAX (ORAL)FLAGYL ER (ORAL)ALINIA SUSPENSION (ORAL)ALINIA TABLET (ORAL)VANCOMYCIN CAPSULE (AG) (ORAL)VANCOMYCIN CAPSULE (ORAL)XIFAXAN (ORAL)DIFICID TABLET ATIONS Discussion: None William Raduege made a motion to accept staff recommendations as presented.o Second - Steve Maikeo All members were in favor of the motiono Motion passesANTIBIOTICS, VAGINALBrand NameCLEOCIN OVULES (VAGINAL)CLINDESSE (VAGINAL)CLINDAMYCIN (VAGINAL)CLEOCIN CREAM (VAGINAL)METRONIDAZOLE (VAGINAL)VANDAZOLE (VAGINAL)METROGEL-VAGINAL (VAGINAL)NUVESSA ECOMMENDATIONSSTATEMODIFICATIONS Discussion: None John Fangman made a motion to accept staff recommendations as presented.o Second - William Raduegeo All members were in favor of the motiono Motion passesSECRETARYMODIFICATIONS

ANTIEMETIC/ANTIVERTIGO AGENTSBrand NameMETOCLOPRAMIDE TABLET (ORAL)PROMETHAZINE TABLET (ORAL)PROCHLORPERAZINE (ORAL)PROMETHAZINE SYRUP (ORAL)MECLIZINE OTC (ORAL)ONDANSETRON TABLETS (ORAL)METOCLOPRAMIDE SOLUTION (ORAL)EMEND CAPSULE (ORAL)ONDANSETRON ODT (ORAL)MECLIZINE (ORAL)ONDANSETRON SOLUTION (ORAL)TRANSDERM-SCOP (TRANSDERM)TRIMETHOBENZAMIDE (ORAL)DICLEGIS (ORAL)GRANISETRON (ORAL)PROCHLORPERAZINE (RECTAL)ZUPLENZ (ORAL)PROMETHAZINE (RECTAL)PROMETHAZINE 50 MG (RECTAL)EMEND POWDER PACKET (ORAL)ANZEMET (ORAL)CESAMET (ORAL)EMEND PACK (ORAL)AKYNZEO (ORAL)METOZOLV ODT (ORAL)APREPITANT CAPSULE (ORAL)DRONABINOL (ORAL)METOCLOPRAMIDE ODT (ORAL)APREPITANT PACK (ORAL)SANCUSO (TRANSDERMAL)VARUBI IONS Discussion: None Pat Towers made a motion to accept staff recommendations as presented.o Second - Catherine Deckero All members were in favor of the motiono Motion passesSECRETARYMODIFICATIONS

ANTIMIGRAINE AGENTS, TRIPTANSBrand NameZOLMITRIPTAN TABLET (AG) (ORAL)RELPAX (ORAL)SUMATRIPTAN (ORAL)ZOLMITRIPTAN ODT (AG) (ORAL)RIZATRIPTAN ODT (ORAL)TREXIMET (ORAL)RIZATRIPTAN TABLET (ORAL)ZOMIG (NASAL)NARATRIPTAN (ORAL)ZOLMITRIPTAN ODT (ORAL)ZOLMITRIPTAN TABLET (ORAL)SUMAVEL DOSEPRO (SUBCUTANE.)SUMATRIPTAN DISP SYRIN (SUBCUTANE.)ALMOTRIPTAN (ORAL)ALMOTRIPTAN (AG) (ORAL)SUMATRIPTAN (NASAL)SUMATRIPTAN VIAL (SUBCUTANE.)SUMATRIPTAN KIT (SUBCUTANE.)IMITREX (NASAL)SUMATRIPTAN KIT (SUN) (SUBCUTANE.)FROVATRIPTAN (ORAL)IMITREX VIAL (SUBCUTANE.)ONZETRA XSAIL (NASAL)FROVA (ORAL)IMITREX KIT (SUBCUTANE.)ZEMBRACE SYMTOUCH ATIONS Discussion: None Kevin Izard made a motion to accept staff recommendations as presented.o Second - John Fangmano All members were in favor of the motiono Motion PassesSECRETARYMODIFICATIONS

ANTIPARASITICS, TOPICALBrand NameCurrentMarketSharePERMETHRIN OTC (TOPICAL)SKLICE (TOPICAL)NATROBA (TOPICAL)EURAX LOTION (TOPICAL)EURAX CREAM (TOPICAL)PERMETHRIN CREAM (TOPICAL)LINDANE SHAMPOO (TOPICAL)SPINOSAD (TOPICAL)ULESFIA (TOPICAL)MALATHION BRAND TARYMODIFICATIONS Discussion: None William Raduege made a motion to accept staff recommendations as presented.o Second - John Fangmano All members were in favor of the motiono Motion PassesANTIVIRALS, ORALBrand NameACYCLOVIR TABLET (ORAL)ACYCLOVIR CAPSULE (ORAL)VALACYCLOVIR (ORAL)FAMCICLOVIR (ORAL)ACYCLOVIR SUSPENSION (ORAL)SITAVIG (BUCCAL)RELENZA (INHALATION)TAMIFLU CAPSULE (ORAL)OSELTAMIVIR CAPSULE (ORAL)TAMIFLU SUSPENSION (ORAL)RIMANTADINE ENDATIONSSTATEMODIFICATIONSSECRETARYMODIFICATIONS Discussion: None Catherine Decker made a motion to accept staff recommendations as presented.o Second - Michael Witkovskyo All members were in favor of the motiono Motion Passes

BLADDER RELAXANT PREPARATIONSCurrentMarketShareBrand NameTOVIAZ (ORAL)GELNIQUE (TRANSDERM.)OXYBUTYNIN SYRUP (ORAL)ENABLEX (ORAL)VESICARE (ORAL)OXYTROL (TRANSDERM.)OXYBUTYNIN ER (AG) (ORAL)OXYBUTYNIN TABLET (ORAL)OXYBUTYNIN ER (ORAL)TOLTERODINE (ORAL)TROSPIUM (ORAL)TOLTERODINE ER (AG) (ORAL)DARIFENACIN ER (AG) (ORAL)TOLTERODINE ER (ORAL)MYRBETRIQ (ORAL)TROSPIUM ER (ORAL)DARIFENACIN ER (ORAL)DETROL LA (ORAL)DETROL RETARYMODIFICATIONS Discussion: None Catherine Decker made a motion to accept staff recommendations as presented.o Second - William Raduegeo All members were in favor of the motiono Motion PassesBPH TREATMENTSBrand NameCurrentMarketShareRAPAFLO (ORAL)0.3%ALFUZOSIN (ORAL)2.2%FINASTERIDE (ORAL)20.2%TAMSULOSIN (ORAL)66.9%TERAZOSIN (ORAL)9.2%DUTASTERIDE (ORAL)0.2%CARDURA XL (ORAL)0.0%DOXAZOSIN (ORAL)0.9%DUTASTERIDE/TAMSULOSIN FICATIONSSECRETARYMODIFICATIONS Discussion: None Michael Witkovsky made a motion to accept staff recommendations as presented.o Second - Will